OTCMKTS:NTFU Nutralife Biosciences (NTFU) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChart Get Nutralife Biosciences alerts: Email Address About Nutralife Biosciences Stock (OTCMKTS:NTFU) 30 days 90 days 365 days Advanced Chart Ad Behind the MarketsWARNING: “Buffett Indicator” flashing for first time in 50 yearsThe stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.Take these 4 steps today to protect your retirement NOW Get Nutralife Biosciences alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume45,202 shsMarket Capitalization$17.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNutraFuels, Inc. manufactures, distributes, and markets a line of oral spray nutritional dietary products to consumers, retailers, and wholesale outlets. The company manufactures and distributes industrial hemp and non-hemp products. Its non-hemp oral spray products include sleep support spray, energy boost spray, weight loss spray, headache and pain spray, spa treatment hair spray, and skin and nails spray. The company also offers Cannabidiol (CBD) oil products, such as HempGenix spray, hemp CBD spray, and E-Vape spray. NutraFuels, Inc. has a collaboration with Pressure BioSciences, Inc. for the development of water-soluble Nanoemulsion-based nutraceuticals. The company was founded in 2010 and is based in Coconut Creek, Florida.Read More… WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)The stock market collapsed and didn't recover for an entire decade. And what we're facing today could be even worse. That's why the actions you take in the next 90 days could be crucial for your financial future.Take these 4 steps today to protect your retirement NOW Receive NTFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutralife Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address NTFU Stock News HeadlinesCoherus BioSciences Stock (NASDAQ:CHRS), Analyst Ratings, Price Targets, PredictionsOctober 25, 2023 | benzinga.comSee More Headlines NTFU Stock Analysis - Frequently Asked Questions How were Nutralife Biosciences' earnings last quarter? Nutralife Biosciences Inc (OTCMKTS:NTFU) released its quarterly earnings data on Tuesday, November, 13th. The company reported ($0.01) EPS for the quarter. The business earned $1.06 million during the quarter. Nutralife Biosciences had a negative net margin of 54.51% and a negative trailing twelve-month return on equity of 204.01%. How do I buy shares of Nutralife Biosciences? Shares of NTFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Nutralife Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Nutralife Biosciences investors own include Ford Motor (F), Prudential Financial (PRU), Cineplex (CGX), CNOOC (CEO), Boston Private Financial (BPFH), Bodycote (BOY) and Blue Apron (APRN). Company Calendar Last Earnings11/13/2018Today9/29/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Dairy Products Sub-IndustryFood Products Current SymbolOTCMKTS:NTFU CUSIPN/A CIKN/A Webwww.nutrafuels.com Phone888-509-8901FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-23,620,000.00 Net Margins-54.51% Pretax MarginN/A Return on Equity-204.01% Return on Assets-115.85% Debt Debt-to-Equity Ratio0.09 Current Ratio0.83 Quick Ratio0.40 Sales & Book Value Annual Sales$1.79 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / BookN/AMiscellaneous Outstanding Shares98,658,000Free FloatN/AMarket Cap$17.20 million OptionableNot Optionable Beta-1.47 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (OTCMKTS:NTFU) was last updated on 9/29/2024 by MarketBeat.com Staff From Our PartnersMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredThe $15 "Insider Secret" That Could Save Your RetirementWhat if I told you there's a $15 stock that a billionaire insider just poured $47 MILLION into? That's righ...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutralife Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutralife Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.